Alexithymia Has No Clinically Relevant Association With Outcome of Multimodal Treatment Tailored to Needs of Patients Suffering From Somatic Symptom and Related Disorders. A Clinical Prospective Study

Introduction: Alexithymia may moderate the effectiveness of treatment and may predict impaired general functioning of patients suffering from somatic symptom and related disorders (SSRD). Aim: We compared alexithymia levels in a clinical prospective study with 234 consecutive patients suffering from SSRD from the Centre of Excellence for Body, Mind, and Health, Tilburg using the Bermond-Vorst Alexithymia Questionnaire, with general population norm scores. Second, we explored treatment outcomes of a multimodal treatment tailored to patient needs by Shared Decision Making (SDM) and Patient Related Outcome Monitoring (PROM) in patients with SSRD. Third, we explored whether alexithymia is associated with treatment outcome. Fourth, we explored if the presence of a chronic medical condition (e.g., diabetes mellitus, cardiovascular diseases) affects the association of alexithymia with treatment outcomes. Results: Compared to norm scores, SSRD patients showed elevated scores on the subscales identifying, verbalizing, and fantasizing, and on the cognitive dimension. All patients benefited from treatment in terms of anxiety, depression, and physical symptoms. The association of alexithymia with treatment outcome was significant, but the effect size was negligible (range odds ratios 1.02-1.25). The association between alexithymia and treatment outcome was stronger in patients suffering from chronic medical conditions compared to patients without chronic medical conditions. However, the effect size of this association was negligible (range odds ratio 0.94-1.12). Discussion: Alexithymia scores are elevated in patients with SSRD compared to general population scores, but the level of alexithymia has no clinically relevant association with treatment outcome both in SSRD patients with and without comorbid chronic medical conditions

Alexithymia · Anxiety · Depression (economics · Population · Psychiatry · Toronto Alexithymia Scale · Clinical Psychology · Fibromyalgia and Chronic Fatigue Syndrome Research · Medicine · Mental Health and Psychiatry · Psychology · Psychosomatic Disorders and Their Treatments

• Interpersonal Emotion Dynamics in Couples With Somatic Symptom Disorder

  Zeynep Emine Okur Güney, Daniela Cardone et al.•Psychosomatic Medicine•2022

  Incluir item

• Type D Personality, Concomitant Depressive and Anxiety Disorders, and Treatment Outcomes in Somatic Symptom and Related Disorders

  Open Access•Lars de Vroege, Eric W de Heer et al.•Frontiers in Psychiatry•2019

  Incluir item

• The Importance of Considering Alexithymia during Initial Stages of Intimate Partner Violence Interventions to Design Adjuvant Treatments

  Open Access•Ángel Romero‐martínez, Marisol Lila et al.•International Journal of…•2019

  Incluir item

• The Predictive Role of Traumatic Experiences, Attachment, and Alexithymia on the Somatisation Process

  Open Access•Cristina Maria Tofan, Ruxandra Curcă•Journal of Child & Adolescent…•2026

  Incluir item

• Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences

  Jacob Cohen, Cohen Cohen et al.•Applied Multiple Regression/Correla…•2013

  Incluir item

• The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales

  Open Access•Kurt Kroenke, Robert L Spitzer et al.•General Hospital Psychiatry•2010

  Incluir item

• Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations

  Open Access•Neil K Aaronson, Martin Müller et al.•Journal of Clinical Epidemiology•1998

  Incluir item

• Patient reported outcome measures could help transform healthcare

  Open Access•Nick Black•BMJ•2013

  Incluir item

• The twenty-item Toronto Alexithymia scale—II. Convergent, discriminant, and concurrent validity

  Open Access•R Michael Bagby, Graeme J Taylor et al.•Journal of Psychosomatic Research•1994

  Incluir item

• The twenty-item Toronto Alexithymia scale—I. Item selection and cross-validation of the factor structure

  Open Access•R Michael Bagby, James D A Parker et al.•Journal of Psychosomatic Research•1994

  Incluir item

• A Brief Measure for Assessing Generalized Anxiety Disorder

  Robert L Spitzer, Carmen Pérez de los Ríos et al.•A.M.A. Archives of Internal…•2006

  Incluir item

• Clinical significance

  Neil S Jacobson, Paula Truax•Journal of Consulting and…•1991

  Incluir item

• The PHQ-9

  Kurt Kroenke, Robert L Spitzer et al.•Journal of General Internal…•2001

  Incluir item

• Influence of Imputation and EM Methods on Factor Analysis when Item Nonresponse in Questionnaire Data is Nonignorable

  Coen A Bernaards, Coen Bernaards et al.•Multivariate Behavioral Research•2000

  Incluir item

• Psychometric Properties of the Bermond–Vorst Alexithymia Questionnaire (BVAQ) in the General Population and a Clinical Population

  Open Access•Lars de Vroege, Wilco H M Emons et al.•Frontiers in Psychiatry•2018

  Incluir item

• Coefficient alpha and the internal structure of tests

  Open Access•Lee J Cronbach•Psychometrika•1951

  Incluir item

• The MOS 36-Item Short-Form Health Survey (SF-36)

  Colleen A Mchorney, WARE JOHNE et al.•Medical Care•1993

  Incluir item